USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 21, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 3, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jun 3, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Apr 1, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 31, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 24, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 13, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Dec 13, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 12, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations; medicines for human purposes; diagnostic preparations for medical purposes; chemical preparations for pharmaceutical and medical purposes; biological preparations for medical purposes; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases.
Class 042
Chemical, biochemical and biological research and analysis; biotechnological research and development; medical and pharmacological research and development services; pharmaceutical product development and evaluation; conducting clinical trials for pharmaceutical products; scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases; chemical molecular analysis and product optimization services provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms.
Class 045
Intellectual property licensing services
Additional Information
Pseudo Mark
ENZYME WORKS; N ZYME WORKS
Classification
International Classes
005
042
045